=Novartis (NVS) reported earnings on Thur 18 July 19 (a/h)
Novartis AG beats by $0.13, beats on revs; raises FY19 guidance
Reports Q2 (Jun) earnings of $1.34 per share, excluding non-recurring items, $0.13 better thanthe S&P Capital IQ Consensus of $1.21; revenues rose 3.7% year/year to $11.76 bln vs the $11.45 bln S&P Capital IQ Consensus.
Core operating income grew 20% (cc, +14% USD) mainly driven by strong sales and productivity, increasing core operating income margin by 3.2 percentage points (cc) to 31.0% of net sales
2019 guidance increased for new focused medicines company: Sales expected to grow mid to high-single digit (cc), core operating income expected to grow low double digit to mid-teens (cc), sales guidance increased for both divisions.
Sales guidance was increased from prior guidance of "growing in the mid single digits" and core operating income was increased from prior guidance of "high single digits."